No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
KBR240517P50000
- 0.21
- 0.000.00%
15min DelayClose Mar 22 12:10 ET
0.00High0.00Low
0.00Open0.21Pre Close0 Volume0 Open Interest50.00Strike Price0.00Turnover8067.90%IV-24.64%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.21Time Value100Contract SizeAmericanOptions Type-0.0438Delta0.0084Gamma314.62Leverage Ratio-309.9408Theta0.0000Rho-13.78Eff Leverage0.0001Vega
Intraday
- 5D
- 1D
News
KBR Inc - Work performance is a 10-year option from 2024 to 2034
KBR Inc - Work performance is a 10-year option from 2024 to 2034
Express News | KBR Inc - Work Has a Period of Performance of 10 Years With Options From 2024 Through 2034
Express News | KBR Health and Human Performance Expertise Recognized With Multiple-Award Contract Worth $43 Billion
BofA Securities Maintains KBR Inc(KBR.US) With Buy Rating, Maintains Target Price $80
BofA Securities analyst Mariana Perez Mora maintains $KBR Inc(KBR.US)$ with a buy rating, and maintains the target price at $80.According to TipRanks data, the analyst has a success rate of 88.0% and
William O'Neill Starts KBR With Buy Rating
KBR (KBR) has an average rating of buy and price targets ranging from $68 to $90, according to analysts polled by Capital IQ.
KBR and Sumitomo Chemical Form Technology Licensing Alliance for Sustainable Propylene Oxide Production
KBR (NYSE: KBR) and Sumitomo Chemical announced today that they have signed an alliance agreement to make KBR an exclusive licensing partner for...